Fuad El-Hibri

Insider Reports History

Entity
Individual
Location
2273 Research Blvd, Suite 400, Rockville, MD
Signature
/s/ Carl A. Valenstein, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fuad El-Hibri:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. Director Common Stock 1.14M $2.07M $1.82 Dec 3, 2021 Direct
Emergent BioSolutions Inc. Director Common Stock 206K $376K $1.82 Dec 3, 2021 Indirect
Aptevo Therapeutics Inc. Director Common Stock 80.3K Dec 3, 2021 Direct
Aptevo Therapeutics Inc. Director Common Stock 7.37K Dec 3, 2021 Indirect

Insider Reports Filed by Fuad El-Hibri

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EBS Emergent BioSolutions Inc. Dec 3, 2021 3 $0 4 Dec 7, 2021 Director
APVO Aptevo Therapeutics Inc. Dec 3, 2021 3 $0 4 Dec 7, 2021 Director
APVO Aptevo Therapeutics Inc. Jun 1, 2021 2 $0 4 Jun 2, 2021 Director